Placebo-controlled comparison of danazol and high-dose medroxyprogesterone acetate in the treatment of endometriosis
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
A prospective, double-blind, placebo-controlled study was designed to evaluate the clinical efficacy and tolerance of danazol and high-dose medroxyprogesterone acetate (MPA) in the treatment of mild-moderate endometriosis. After laparoscopical confirmation of endometriosis, 59 patients were randomized to receive danazol (200 mg 3 times daily), MPA (100 mg daily) or placebo for 6 months. Clinical examinations were done before and 1, 3, 6 and 12 months after the beginning of the study, and a 2nd laparoscopy 6 months after termination of the medication. Eighteen patients in the danazol group, 16 in the MPA group and 17 in the placebo group completed the trial. Total or partial resolution of peritoneal implants was observed in 60% of the patients receiving danazol and in 63% of the patients receiving MPA. In the placebo group, resolution was observed in 18%, while the size of the implants was estimated to be increased in 23% of the patients. In relation to placebo, danazol and MPA significantly alleviated endometriosis-associated pelvic pain, lower back pain and defecation pain, but they did not differ from each other in these actions. The appearance of acne, muscle cramps, edema, weight gain and spotting bleeding complicated MPA treatment. The present results indicate that because of good efficacy and tolerance, high-dose MPA is a useful alternative in the hormonal treatment of endometriosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Danazol is effective in treating endometriosis-related pain [220] and its efficacy seems to persist also after the discontinuation of therapy [215].”
From Hormonal treatments for endometriosis: The endocrine background (2022) · cites this paper as [215]
In the citing paper
“MPA appeared to be more effective than placebo [214] and as effective as danazol [215] and GnRH-agonists [216, 217] in reducing endometriosis-related pain.”
From Hormonal treatments for endometriosis: The endocrine background (2022) · cites this paper as [215]
In the citing paper
“However, six RCTs have already demonstrated that various treatments used for the relief of pain in women with symptomatic endometriosis are far superior to placebo (Telimaa et al., 1987;Dlugi et al., 1990;Fedele et al., 1993;Bergqvist et al., 1998;Harada et al., 2008;Strowitzki et al., 2010b).”
From “Waiting for Godot”: a commonsense approach to the medical treatment of endometriosis (2011) · cites this paper as Telimaa et al., 1987
Citations
Cites
Classification of Endometriosis
(1979) · Fertility and Sterility · doi:10.1016/s0015-0282(16)44409-2 · Cited by 304
Danazol: Endocrine pharmacology and therapeutic applications
Barbieri, R. L., & Ryan, K. J. (1981) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(81)90611-6 · Cited by 208
Danazol in the treatment of endometriosis: analysis of 100 cases with a 4-year follow-up
Barbieri, R. L., Evans, S., & Kistner, R. W. (1982) · Fertility and Sterility · doi:10.1016/s0015-0282(16)46331-4 · Cited by 172
Frank, R. T. (1949) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(49)90275-6 · Cited by 159
Treatment of endometriosis with danazol: report of a 6-year prospective study
Buttram, V. C., Reiter, R. C., & Ward, S. (1985) · Fertility and Sterility · doi:10.1016/s0015-0282(16)48431-1 · Cited by 132
Estrogen and progestin receptors in endometriosis lesions: Comparison with endometrial tissue
Jänne, O. A., Kauppila, A., Kokko, E., Lantto, T., Rönnberg, L., & Vihko, R. (1981) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(15)33278-6 · Cited by 130
Self-citationEndocrine Properties and Clinical Application of Danazol
Wallach, E. E., & Dmowski, W. P. (1979) · Fertility and Sterility · doi:10.1016/s0015-0282(16)43869-0 · Cited by 119
Progestin Therapy of Endometrial, Breast and Ovarian Carcinoma: A review of clinical observations
Kauppila, A. (1984) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.3109/00016348409156700 · Cited by 115
Self-citationDmowski, W. P., & Mr, C. (1975) · PubMed · Cited by 105
Vierikko, P., Kauppila, A., Rönnberg, L., & Vihko, R. (1985) · Fertility and Sterility · doi:10.1016/s0015-0282(16)48376-7 · Cited by 99
Self-citation
Research works printed but not linked: 4
- Dmowski W. P., 1975, Am.J. Obstet. Gynecol., 46, 147
- Rönnberg L., 1979, Postgrad. Med. J., 55, 21
- Moghissi K. S., 1976, Obstet. Gynecol., 47, 265
- Roland M., 1976, J. Reprod. Med., 17, 249
Cited by
Giudice, L. C., & Kao, L. C. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17403-5 · Cited by 3,166
Olive, D. L., & Schwartz, L. B. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306173282407 · Cited by 675
Evers, J. L. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09417-5 · Cited by 590
Sutton, C. J. G., Ewen, S. P., Whitelaw, N., & Haines, P. (1994) · Fertility and Sterility · doi:10.1016/s0015-0282(16)56990-8 · Cited by 525
Endometriosis and pelvic pain: epidemiological evidence of the relationship and implications
Fauconnier, A., & Chapron, C. (2005) · Human Reproduction Update · doi:10.1093/humupd/dmi029 · Cited by 522
“, 2004) and by multidimensional verbal scales in two (Telimaa et al., 1987; Dlugi et al., 1990).”
BackgroundMethodInfluential
Metadata
- Authors
- Telimaa, S., Puolakka, J., & Kauppila, A.
- Affiliations
- University of Oulu (FI)
- Venue
- Gynecological Endocrinology
- Publisher
- Informa UK Limited
- Published
- 1987-01
- Volume
- 1
- Issue
- 1
- Pages
- 13-23
- ISSN
- 0951-3590 (ISSN-L)
- 1473-0766
- OpenAlex
- W1990658851
- Cited by
- 241
- References
- 31
- Citations by year
- 2026: 5 · 2025: 1 · 2024: 6 · 2022: 3 · 2021: 5 · 2020: 5 · 2019: 1 · 2018: 4 · 2017: 12 · 2016: 2 · 2015: 9 · 2014: 6 · 2013: 4 · 2012: 7
- FWCI
- 6.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Gynecological Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Health Sciences › Medicine › Obstetrics and Gynecology › Ectopic Pregnancy Diagnosis and Management
- Health Sciences › Medicine › Obstetrics and Gynecology › Gynecological conditions and treatments
- Keywords
- endometriosis, danazol, medroxyprogesterone acetate, hormone therapy, peritoneal implants, pelvic pain, drug tolerability, treatment efficacy
- MeSH terms
- Adult, Antineoplastic Agents, Clinical Trials as Topic, Danazol, Dose-Response Relationship, Drug, Double-Blind Method, Endometriosis, Female, Humans, Infertility, Female, Medroxyprogesterone, Ovarian Neoplasms, Pelvic Neoplasms, Laparoscopy, Pregnadienes, Pregnancy, Random Allocation, Medroxyprogesterone Acetate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Placebo-controlled comparison of danazol and high-dose medroxyprogesterone acetate in the treatment of endometriosis. https://app.cochat.ai/papers/10.3109/09513598709082692
- The paper
- Telimaa, S., Puolakka, J., & Kauppila, A. (1987). Placebo-controlled comparison of danazol and high-dose medroxyprogesterone acetate in the treatment of endometriosis. Gynecological Endocrinology. https://doi.org/10.3109/09513598709082692
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.